Former Fluidigm Microfluidics Business Becomes Biomark Scientific
The microfluidics business of Standard BioTools (formerly Fluidigm) was acquired by healthcare investor ARCHIMED. On November 3, 2026, it relaunched as an independent company, Biomark Scientific. Standard BioTools is also selling its mass cytometry business and merging with a drug developer.
Microfluidics acquisition completed
Standard BioTools announced the agreement to sell its microfluidics business to ARCHIMED on October 5, 2026. The deal closed on November 3, and the price was not disclosed.
Biomark Scientific operates as a stand-alone company within ARCHIMED. The company says it keeps the same team and will continue its products and services. Luke Stewart is its Chief Commercial Officer.
Products and customers
Its core line is the Biomark platform for high-throughput, multi-assay genomics. The line includes the Biomark X9, which automates PCR, qPCR and NGS library preparation. Its main customers are research institutions, public health laboratories and biobanks. The products are for research use only.
The Biomark business goes back to Fluidigm, founded in 1999 and renamed Standard BioTools in 2022.
Sale of the mass cytometry business
On September 30, 2026, Standard BioTools announced an agreement to sell its mass cytometry business for 5.5 million US dollars in cash to Element Biosystems, LLC, a vehicle formed by GMT Venture Partners. The business was first to be sold to Multiplex Bio under an agreement announced on July 28. After GMT Venture's proposal, the two parties agreed to end that agreement.
Merger with Treeline Biosciences
In June 2026, Standard BioTools agreed to merge with Treeline Biosciences, a cancer drug developer. The combined company is to be listed on Nasdaq under the ticker TRLN.
What comes next
Both the mass cytometry sale and the Treeline merger depend on Standard BioTools stockholder approval and other conditions. Both are expected to close by the end of 2026.
Source: Treeline reverse merger with Standard BioTools (BioPharma Dive, June 9, 2026)